Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hargreaves Lansdown PLC Director's Dealing 2018

Oct 15, 2018

4868_dirs_2018-10-15_de4dfe48-80f9-4567-ac09-d887c2b07171.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0777E

Hargreaves Lansdown PLC

15 October 2018

Hargreaves Lansdown plc ("the Company")

Director/PDMR/PCA Transaction - Initial Notification

The Company announces that it was notified on 12 October 2018, of the following joint acquisition ("Dealings") in American Depositary Receipts representing the Company's ordinary shares of 4p each ("Ordinary Shares") by Deanna Oppenheimer who is a director/person discharging managerial responsibility in the Company. The Dealings took place on 12 October 2018.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

DEANNA OPPENHEIMER

2

Reason for the notification

a)

Position/status

DIRECTOR

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

HARGREAVES LANSDOWN PLC

b)

LEI

2138008ZCE93ZDSESG90

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

AMERICAN DEPOSITARY RECEIPTS (ADRs) IN

HARGREAVES LANSDOWN PLC (EACH ADR REPRESENTS 2 ORDINARY SHARES OF  0.4p)

US4125441083

b)

Nature of the transaction

PURCHASE OF ADRs INTO ACCOUNT HELD JOINTLY BY DEANNA OPPENHEIMER AND JOHN OPPENHEIMER

c)

Price(s) and volume(s)

Price(s) Volume(s)
$49.50 10,000

d)

Aggregated information

- Aggregated volume

- Price

10,000

$495,000

e)

Date of the transaction

12 OCTOBER 2018

f)

Place of the transaction

OUTSIDE TRADING VENUE

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

JOHN OPPENHEIMER

2

Reason for the notification

a)

Position/status

PCA

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

HARGREAVES LANSDOWN PLC

b)

LEI

2138008ZCE93ZDSESG90

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

AMERICAN DEPOSITARY RECEIPTS (ADRs) IN

HARGREAVES LANSDOWN PLC (EACH ADR REPRESENTS 2 ORDINARY SHARES OF  0.4p)

US4125441083

b)

Nature of the transaction

PURCHASE OF ADRs INTO ACCOUNT HELD JOINTLY BY DEANNA OPPENHEIMER AND JOHN OPPENHEIMER

c)

Price(s) and volume(s)

Price(s) Volume(s)
$49.50 10,000

d)

Aggregated information

- Aggregated volume

- Price

10,000

$495,000

e)

Date of the transaction

12 OCTOBER 2018

f)

Place of the transaction

OUTSIDE TRADING VENUE

Paula Watts

Company Secretary

Copies of our announcements are available on our website http://www.hl.co.uk/investor-relations/regulatory-announcements

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLELFFVBFLFBZ